Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on AP707 for chronic back pain reports efficacy and tolerability data, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Lower Back Pain
• Pain

Drugs mentioned

• AP707

Snippet

Sponsor: Apurano Pharmaceuticals GmbH | Conditions: Pain, Pain Syndrome | Phase 3 | Status: UNKNOWN